CSF YKL-40 levels are predominantly increased in progressive compared to relapsing MS and are associated with a higher risk of disability accumulation and correlated with MRI measures indicative of spinal cord atrophy [32]. Here, CHI3L1 is linked to myeloid sarcoma.